The Pennant Group, Inc. (PNTG)
USD 26.06
(-0.53%)
USD 26.06
(-0.53%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 539.69 Million USD | 5.38% |
| 2022 | 512.11 Million USD | -3.43% |
| 2021 | 530.29 Million USD | 4.6% |
| 2020 | 506.97 Million USD | 13.23% |
| 2019 | 447.75 Million USD | 356.18% |
| 2018 | 98.15 Million USD | 11.17% |
| 2017 | 88.28 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 602.46 Million USD | 4.19% |
| 2024 Q1 | 578.24 Million USD | 7.14% |
| 2023 Q3 | 520.31 Million USD | 0.95% |
| 2023 Q4 | 539.69 Million USD | 3.72% |
| 2023 FY | 539.69 Million USD | 5.38% |
| 2023 Q1 | 508.15 Million USD | -0.77% |
| 2023 Q2 | 515.41 Million USD | 1.43% |
| 2022 Q4 | 512.11 Million USD | 1.43% |
| 2022 Q1 | 507.43 Million USD | -4.31% |
| 2022 FY | 512.11 Million USD | -3.43% |
| 2022 Q3 | 504.88 Million USD | 1.7% |
| 2022 Q2 | 496.43 Million USD | -2.17% |
| 2021 Q2 | 529.8 Million USD | 2.02% |
| 2021 FY | 530.29 Million USD | 4.6% |
| 2021 Q4 | 530.29 Million USD | 0.21% |
| 2021 Q3 | 529.2 Million USD | -0.11% |
| 2021 Q1 | 519.32 Million USD | 2.44% |
| 2020 Q1 | 458.98 Million USD | 2.51% |
| 2020 Q2 | 469.24 Million USD | 2.24% |
| 2020 FY | 506.97 Million USD | 13.23% |
| 2020 Q4 | 506.97 Million USD | 5.6% |
| 2020 Q3 | 480.11 Million USD | 2.32% |
| 2019 Q1 | 338.45 Million USD | 244.83% |
| 2019 FY | 447.75 Million USD | 356.18% |
| 2019 Q4 | 447.75 Million USD | 23.34% |
| 2019 Q3 | 363.02 Million USD | 1.78% |
| 2019 Q2 | 356.66 Million USD | 5.38% |
| 2018 Q4 | 98.15 Million USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | 98.15 Million USD | 11.17% |
| 2017 FY | 88.28 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | 89.929% |
| Addus HomeCare Corporation | 1.02 Billion USD | 47.318% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | -152.721% |
| Amedisys, Inc. | 2.06 Billion USD | 73.804% |
| American Oncology Network, Inc. | 374.45 Million USD | -44.128% |
| Astrana Health, Inc. | 933.36 Million USD | 42.178% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 67.035% |
| IMAC Holdings, Inc. | 1.14 Million USD | -47070.88% |
| biote Corp. | 155.29 Million USD | -247.526% |
| Cryo-Cell International, Inc. | 61.22 Million USD | -781.549% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | 20.554% |
| COMPASS Pathways plc | 275.98 Million USD | -95.549% |
| DocGo Inc. | 490.45 Million USD | -10.04% |
| The Ensign Group, Inc. | 4.17 Billion USD | 87.081% |
| Healthcare Services Group, Inc. | 803.18 Million USD | 32.806% |
| InnovAge Holding Corp. | 547.66 Million USD | 1.455% |
| Assure Holdings Corp. | 7.51 Million USD | -7082.473% |
| The Joint Corp. | 87.15 Million USD | -519.261% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | 75.833% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -6688.041% |
| ModivCare Inc. | 1.76 Billion USD | 69.462% |
| NewGenIvf Group Limited | 1.64 Million USD | -32658.974% |
| Novo Integrated Sciences, Inc. | 35.56 Million USD | -1417.561% |
| Option Care Health, Inc. | 3.32 Billion USD | 83.785% |
| P3 Health Partners Inc. | 860.96 Million USD | 37.316% |
| P3 Health Partners Inc. | 860.96 Million USD | 37.316% |
| Surgery Partners, Inc. | 7.01 Billion USD | 92.311% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -10862.015% |
| Talkspace, Inc. | 142.22 Million USD | -279.473% |
| Talkspace, Inc. | 142.22 Million USD | -279.473% |
| The Oncology Institute, Inc. | 219.41 Million USD | -145.965% |
| The Oncology Institute, Inc. | 219.41 Million USD | -145.965% |